Attention to detail and a permissive set-up: crucial for an effective TURBT
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://www.nature.com/articles/s41585-021-00441-9.pdf
Reference10 articles.
1. Das, A. et al. Surgeon scorecards improve muscle sampling on transurethral resection of bladder tumor and recurrence outcomes in patients with nonmuscle invasive bladder cancer. J. Urol. 205, 693–700 (2021).
2. Gontero, P. et al. The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/grade 3 bladder cancer treated with bacille Calmette-Guérin. BJU Int. 118, 44–52 (2016).
3. Mariappan, P. et al. Predicting grade and stage at cystoscopy in newly presenting bladder cancers-a prospective double-blind clinical study. Urology 109, 134–139 (2017).
4. Del Giudice, F. et al. Prospective assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non-muscle-invasive bladder cancer patients candidate for repeated transurethral resection. Eur. Urol. 77, 101–109 (2020).
5. Mariappan, P. et al. Enhanced quality and effectiveness of transurethral resection of bladder tumour in non-muscle-invasive bladder cancer: a multicentre real-world experience from scotland’s quality performance indicators programme. Eur. Urol. 78, 520–530 (2020).
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Re: Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non–muscle-invasive Bladder Cancer;European Urology;2024-08
2. Differentiation of bladder cancer with water flow elastography (WaFE);Journal of the Mechanical Behavior of Biomedical Materials;2024-02
3. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor;Journal of Experimental & Clinical Cancer Research;2024-01-20
4. Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non–muscle-invasive Bladder Cancer;European Urology Oncology;2024-01
5. Identification of Risk Factors of Tumor Recurrence and Model Establishing for Patients with Intermediate and Higher Risk NMIBC Followed by Intravesical BCG Instillation After TmLRBT or TURBT;2023-10-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3